HK1247916A1 - 新型5-ht2拮抗劑 - Google Patents

新型5-ht2拮抗劑

Info

Publication number
HK1247916A1
HK1247916A1 HK18107294.8A HK18107294A HK1247916A1 HK 1247916 A1 HK1247916 A1 HK 1247916A1 HK 18107294 A HK18107294 A HK 18107294A HK 1247916 A1 HK1247916 A1 HK 1247916A1
Authority
HK
Hong Kong
Prior art keywords
antagonists
novel
Prior art date
Application number
HK18107294.8A
Other languages
English (en)
Inventor
Lars Pettersson
Original Assignee
Anamar Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anamar Ab filed Critical Anamar Ab
Publication of HK1247916A1 publication Critical patent/HK1247916A1/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/06Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • A61K31/41551,2-Diazoles non condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • A61K31/4161,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Indole Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Furan Compounds (AREA)
  • Pyrrole Compounds (AREA)
HK18107294.8A 2015-06-22 2018-06-04 新型5-ht2拮抗劑 HK1247916A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15173111.4A EP3109237A1 (en) 2015-06-22 2015-06-22 Novel 5-ht2 antagonists
PCT/EP2016/064446 WO2016207231A1 (en) 2015-06-22 2016-06-22 Novel 5-ht2 antagonists

Publications (1)

Publication Number Publication Date
HK1247916A1 true HK1247916A1 (zh) 2018-10-05

Family

ID=53496439

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18107294.8A HK1247916A1 (zh) 2015-06-22 2018-06-04 新型5-ht2拮抗劑

Country Status (22)

Country Link
US (1) US10544103B2 (zh)
EP (2) EP3109237A1 (zh)
JP (1) JP6718886B2 (zh)
KR (1) KR102610630B1 (zh)
CN (1) CN107787321B (zh)
AU (1) AU2016282325B2 (zh)
CA (1) CA2988033C (zh)
CY (1) CY1123880T1 (zh)
DK (1) DK3310762T3 (zh)
ES (1) ES2819499T3 (zh)
HK (1) HK1247916A1 (zh)
HR (1) HRP20201485T1 (zh)
HU (1) HUE050667T2 (zh)
IL (1) IL256496B (zh)
LT (1) LT3310762T (zh)
MX (1) MX2017016939A (zh)
PL (1) PL3310762T3 (zh)
PT (1) PT3310762T (zh)
RS (1) RS61266B1 (zh)
RU (1) RU2706229C2 (zh)
SI (1) SI3310762T1 (zh)
WO (1) WO2016207231A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3753924A1 (en) 2019-06-18 2020-12-23 AnaMar AB New tricyclic 5-ht2 antagonists
WO2021042038A1 (en) * 2019-08-29 2021-03-04 University Of Cincinnati Treatment of pain by targeting nr4a1
AU2023250955A1 (en) * 2022-04-07 2024-10-17 Corbus Pharmaceuticals, Inc. Cannabinoid receptor 1 antagonists/inverse agonists and uses thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US641992A (en) * 1898-03-31 1900-01-23 Guillaume Arnaud Nussbaum Steam-generator.
GB1223491A (en) * 1967-10-13 1971-02-24 American Home Prod Guanidines
US4107326A (en) 1977-05-06 1978-08-15 American Cyanamid Company Novel benzylideneaminoguanidines
DZ3335A1 (fr) 2000-03-23 2001-09-27 Solvay Pharm Bv Derives de 4,5-dihydro-1h-pyrazole ayant une activite antagoniste de cb1
CA2532316A1 (en) 2003-07-15 2005-01-27 Bayer Healthcare Ag Pyrazolines as par-1 antagonists for treatment of cardiovascular diseases
DE102004061750A1 (de) 2004-12-22 2006-07-06 Bayer Healthcare Ag Heteroaryl-substituierte Pyrazoline
DE102005014089A1 (de) 2005-03-22 2006-09-28 Schering Ag Tetrahydronaphthalinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer
JP5157892B2 (ja) * 2006-02-20 2013-03-06 アステラス製薬株式会社 アミド誘導体またはその塩
CN101431994A (zh) 2006-04-27 2009-05-13 索尔瓦药物有限公司 CBx大麻素受体调节剂作为钾通道调节剂的用途
EP1882475A1 (en) * 2006-07-26 2008-01-30 Novartis AG Method of treating disorders mediated by the fibroblast growth factor receptor
AR062907A1 (es) 2006-09-22 2008-12-17 Solvay Pharm Bv Derivados de sulfonilpirazol y sulfonilpirazolincarboxamidina como antagonistas de 5-ht6
AR070898A1 (es) * 2008-03-18 2010-05-12 Solvay Pharm Bv Derivados de arilsulfonil pirazolin carboxamidina como antagonistas de 5-ht6
EP2470270A1 (en) * 2009-07-31 2012-07-04 AnaMar AB Compounds for treatment of inflammation
WO2012008528A1 (ja) * 2010-07-15 2012-01-19 大日本住友製薬株式会社 ピラゾール化合物
CA2837524C (en) 2011-07-01 2019-08-20 Merck Patent Gmbh Dihydropyrazoles

Also Published As

Publication number Publication date
EP3310762A1 (en) 2018-04-25
WO2016207231A1 (en) 2016-12-29
BR112017027371A2 (pt) 2018-11-06
AU2016282325B2 (en) 2020-06-25
HRP20201485T1 (hr) 2020-12-11
KR20180022799A (ko) 2018-03-06
PL3310762T3 (pl) 2020-12-28
JP2018522829A (ja) 2018-08-16
JP6718886B2 (ja) 2020-07-08
MX2017016939A (es) 2018-11-09
NZ737537A (en) 2020-10-30
EP3109237A1 (en) 2016-12-28
RS61266B1 (sr) 2021-01-29
PT3310762T (pt) 2020-09-30
CA2988033A1 (en) 2016-12-29
SI3310762T1 (sl) 2020-11-30
IL256496A (en) 2018-02-28
DK3310762T3 (da) 2020-10-12
US20180155292A1 (en) 2018-06-07
CA2988033C (en) 2021-06-08
CY1123880T1 (el) 2022-03-24
HUE050667T2 (hu) 2021-01-28
US10544103B2 (en) 2020-01-28
IL256496B (en) 2020-11-30
KR102610630B1 (ko) 2023-12-06
ES2819499T3 (es) 2021-04-16
CN107787321A (zh) 2018-03-09
CN107787321B (zh) 2021-10-01
RU2706229C2 (ru) 2019-11-15
AU2016282325A1 (en) 2017-12-21
RU2017140648A (ru) 2019-07-24
RU2017140648A3 (zh) 2019-07-29
LT3310762T (lt) 2020-10-12
EP3310762B1 (en) 2020-08-05

Similar Documents

Publication Publication Date Title
HK1252163A1 (zh) 受體
GB201514875D0 (en) Receptor
IL254476A0 (en) Heterocyclylmethyl-thianouracil as adenosine-a2b receptor antagonists
IL258737A (en) Antagonists ep4
PL3259424T3 (pl) Okucie wychylne
SG11202002207QA (en) Trpv2 antagonists
AU361999S (en) Ballustrade
PL2985779T3 (pl) Podstawa uchwytu bezpiecznikowego
HK1247916A1 (zh) 新型5-ht2拮抗劑
RS59627B1 (sr) Kompozicija amina maskiranog mirisa
PL2902575T3 (pl) System okuciowy
GB2540162B (en) Tracers
GB201707862D0 (en) Tracers
GB2530305B (en) Tracers
GB201418365D0 (en) Tracers
GB201409664D0 (en) Tracers
ZA201807767B (en) Angiotensin-1-receptor antagonists
PT3464324T (pt) Antagonistas de recetores da angiotensina-1
GB2528073B (en) Making diodes
GB201508463D0 (en) Minifig art
GB201509453D0 (en) Tracers
AU2015165V (en) PWBC12 Chamelaucium uncinatum
AU362754S (en) Playsuit
AU2015211V (en) SGIBL01-0 Scabiosa columbaria
AU2015212V (en) SGIPU2-0 Scabiosa columbaria